Hydralazine/isosorbide dinitrate in African-American patients with moderate-to-severe heart failure also on standard treatment

Trial Profile

Hydralazine/isosorbide dinitrate in African-American patients with moderate-to-severe heart failure also on standard treatment

Completed
Phase of Trial: Phase III

Latest Information Update: 27 Mar 2012

At a glance

  • Drugs Hydralazine/isosorbide dinitrate (Primary)
  • Indications Heart failure
  • Focus Therapeutic Use
  • Acronyms A-HeFT
  • Most Recent Events

    • 27 Mar 2012 Results reporting hospital readmission and time to hospital readmission endpoints presented at the 61st Annual Scientific Session of the American College of Cardiology.
    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top